1)Gregg RW, Molepo JM, Monpetit VJ, et al:Cisplatin neurotoxicity:the relationship between dosage, time, and platinum concentration in neurologic tissues, and morphologic evidence of toxicity. J Clin Oncol 10:795-803, 1992
2)Cavaletti G, Marzorati L, Bogliun G, et al:Cisplatin-induced peripheral neurotoxicity is dependent on total-dose intensity and single-dose intensity. Cancer 69:203-207, 1992
3)Heinzlef O, Lotz JP and Roullet E:Severe neuropathy after high dose carboplatin in three patients receiving multidrug chemotherapy. J Neurol Neurosurg Psychiatry 64:667-669, 1998
4)Argyriou AA, Polychronopoulos P, Iconomou G, et al:A review on oxaliplatin-induced peripheral nerve damage. Cancer Treat Rev 34:368-377, 2008
5)Sparano JA, Wang M, Martino S, et al:Weekly paclitaxel in the adjuvant treatment of breast cancer. N Engl J Med 358:1663-1671, 2008
6)Scripture CD, Figg WD and Sparreboom A:Peripheral neuropathy induced by paclitaxel:recent insights and future perspectives. Curr Neuropharmacol 4:165-172, 2006
7)Hensley ML, Peterson B, Silver RT, et al:Risk factors for severe neuropsychiatric toxicity in patients receiving interferon alfa-2b and low-dose cytarabine for chronic myelogenous leukemia:analysis of Cancer and Leukemia Group B 9013. J Clin Oncol 18:1301-1308, 2000
8)Denicoff KD, Rubinow DR, Papa MZ, et al:The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann Intern Med 107:293-300, 1987
9)Albers J, Chaudhry V, Cavaletti G, et al:Interventions for preventing neuropathy caused by cisplatin and related compounds. Cochrane Database Syst Rev CD005228, 2007
10)Kirchmair R, Walter DH, Ii M, et al:Antiangiogenesis mediates cisplatin-induced peripheral neuropathy:attenuation or reversal by local vascular endothelial growth factor gene therapy without augmenting tumor growth. Circulation 111:2662-2670, 2005
11)Kalkanis JG, Whitworth C and Rybak LP:Vitamin E reduces cisplatin ototoxicity. Laryngoscope 114:538-542, 2004
12)Pelgrims J, De Vos F, Van den Brande J, et al:Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy:report of 12 cases and a review of the literature. Br J Cancer 82:291-294, 2000
13)Buesa JM, Garcia-Teijido P, Losa R, et al:Treatment of ifosfamide encephalopathy with intravenous thiamin. Clin Cancer Res 9:4636-4637, 2003
14)Rummans TA, Frost M, Suman VJ, et al:Quality of life and pain in patients with recurrent breast and gynecologic cancer. Psychosomatics 39:437-445, 1998
15)片岡理恵:がん患者965名に対するWebアンケート調査結果.MMJ 4:533-536,2008
16)Ichinose T, Yamase M, Yokomatsu Y, et al:Acute myocardial infarction with myocardial perfusion defect detected by contrast-enhanced computed tomography. Intern Med 48:1235-1238, 2009
17)Clark AJ, Ahmedzai SH, Allan LG, et al:Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain. Curr Med Res Opin 20:1419-1428, 2004
18)Trescot AM, Datta S, Lee M, et al:Opioid pharmacology. Pain Physician 11:S133-153, 2008